ClinConnect ClinConnect Logo
Search / Trial NCT00792259

Topcon 3D OCT-1000 Optical Coherence Tomography System

Launched by TOPCON MEDICAL SYSTEMS, INC. · Nov 14, 2008

Trial Information

Current as of June 20, 2025

Completed

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Retinal Disease Study
  • No Retinal Disease:
  • Inclusion Criteria:
  • Male or female
  • Between 18 and 80 years of age
  • Either eye, but only one eye per subject will be enrolled
  • Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.
  • Exclusion Criteria:
  • Any known ocular disease
  • Any systemic disease that could result in ocular manifestations such as hypertension, diabetes, heart disease, etc.
  • Topcon image quality factor ≤ 44 or Stratus signal strength \< 5.
  • Retinal Disease
  • Inclusion Criteria:
  • Male or female
  • Between 18 and 80 years of age
  • Either eye, but only one eye per subject will be enrolled
  • Symptoms consistent with one of the following retinal diseases: diabetic macular edema, cystoid macular edema, epiretinal membrane, macular hole, wet AMD and dry AMD for which OCT imaging is warranted. At lease one (1) case each of these diseases will be included in the study
  • A range of retinal thickness will be included
  • Topcon image quality factor ≥ 45 or Stratus signal strength ≥ 5.
  • Exclusion Criteria:
  • Presence of glaucoma
  • Topcon image quality factor ≤ 44 or Stratus signal strength \< 5.

About Topcon Medical Systems, Inc.

Topcon Medical Systems, Inc. is a leading provider of advanced ophthalmic equipment and technology, dedicated to enhancing the diagnosis and treatment of eye care conditions. With a commitment to innovation and quality, Topcon develops a comprehensive range of diagnostic instruments and software solutions that empower eye care professionals to deliver superior patient care. The company actively engages in clinical trials to advance the field of ophthalmology, ensuring that their products meet the highest standards of efficacy and safety. Through collaboration with healthcare providers and researchers, Topcon aims to improve patient outcomes and drive advancements in vision science.

Locations

Bronxville, New York, United States

New York, New York, United States

New York, New York, United States

New York, New York, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials